Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 814-233-8 | CAS number: 444649-70-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From June 09, 2015 to June 26, 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- typing error
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Specific details on test material used for the study:
- Batch no.: JBGJ0045R
Appearance: clear yellowish liquid - Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Source: Velaz Prague, Czech Republic
Age: At least 8-12 weeks; female animals were non-pregnant and nulliparous
Acclimatization: at least 5 days
Temperature: 22 ± 2°C, relative humidity : 55 ± 10% and light regimen: 12-hour light /12-hour dark cycle
Diet: laboratory food Altromin (Altromin Spezialfutter GmbH, Germany, ad libitum
Water: tap water for human consumption, ad libitum - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- The required amount of the test substance (according to the body weight and dose) was mixed with vehicle (carboxymethyl cellulose - 1% solution) shortly before administration. The test substance was administered in a single dose by gavage using a metal stomach tube. Animals were fasted prior to dosing (food but not water were withheld over-night). Following the period of fasting, the animals were weighted and the test substance administered. After the test isubstance had been administered, food was withheld for further 3-4 hours.
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 3 males and 6 females
- Control animals:
- no
- Details on study design:
- - Animals were observed individually immediately after the administration of the test substance and then ½, 1, 2, and 4 hours later. Then each animal was inspected daily for the next 14 days. Observations included changes in skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic and central nervous systems, and somatomotor activity and behaviour pattern. Attention was directed to observations of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
- Individual weights of animals were determined shortly before the test substance was administered and at weekly thereafter. Weight differences after first and second week after application were calculated and recorded.
- All test animals were subjected to gross necropsy. Full, detailed gross necropsy included careful examination of external surface of the body, all orifices, and cranial, thoracic and abdominal cavities and their contents. All gross pathological changes were recorded for each animal. - Preliminary study:
- The starting dose was selected from the fixed dose levels of 5, 50, 300, and 2000 mg/kg bw. Available information indicated that the test substance is likely to be nontoxic considering to acute toxicity. A limit dose of 2000 mg/kg bw was used as starting dose. Group of 3 rat’s females were dosed. Test substance-related mortality was not produced during 24 hours; group of 3 rat’s females and group of 3 rat’s males were tested at the same dose.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- >= 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- All 6/6 females and 3/3 males survived the limit dose 2000 mg/kg bw. No further dosing was necessary.
- Clinical signs:
- other: No mortality was observed during the study. Animals lived through observation period without important visible signs of intoxication. Neither change of health nor negative reactions were registered.
- Gross pathology:
- All animals (6 females and 3 males) were necropsied. During necropsy, no macroscopically changes were noticed.
- Interpretation of results:
- other: CLP criteria not met
- Remarks:
- does not need to be classified
- Conclusions:
- Under the study conditions, the rat LD50 was determined to be ≥ 2000 mg/kg bw.
- Executive summary:
A study was conducted to determine the acute oral toxicity of the test substance according to OECD Guideline 423, in compliance with GLP. The test substance was administered by gavage to 6 female and 3 male rats at a limit dose of 2000 mg/kg bw. All 6/6 females and 3/3 males survived the limit dose of 2000 mg/kg bw. No further dosing was necessary. No body weight losses were recorded one and two weeks after administration of the test substance. No important symptoms were observed at the dosage of 2000 mg/kg bw during first 4 h neither in females nor in males or in 14 day observation period. During necropsy, no macroscopically changes were noticed. Under the study conditions, the rat LD50 was determined to be ≥ 2000 mg/kg bw (Hozova, 2015).
Based on the results, the test substance was classified in category 5/Unclassified with the cut off LD50 ≥ 5000 mg/kg bw, after single oral administration to Wistar rats.
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From June 17, 2015 to July 21, 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- but did not affect the validity of the study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- but did not affect the validity of the study
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Justification for non-LLNA method:
- -
- Specific details on test material used for the study:
- Batch no.: JBGJ0045R
Purity: 100% (UVCB)
Appearance: clear yellowish liquid - Species:
- mouse
- Strain:
- CBA/Ca
- Remarks:
- CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- Source: Harlan Laboratories B.V. Postbus 6174 5960 AD Horst / The Netherlands
Acclimatization: at least 5 days
Body weight: ca. 20g
Temperature: ca. 22±2°C, relative humidity : ca. 45-65% and light regimen: 12-hour light /12-hour dark cycle
Diet: 2018C Teklad Global 18% protein rodent diet, ad libitum
Water: tap water, ad libitum - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 0, 0.5, 1 and 2.5% (w/w)
(Pre-tests: 50, 25, 10 and 5%) - No. of animals per dose:
- 4
- Details on study design:
- Three groups each of four female mice were treated with different concentrations (25 µL of 0, 0.5, 1, and 2.5% (w/w) in acetone/olive oil (4+1, v/v)) of the test substance by topical application at the dorsum of each ear once daily each on three consecutive days. The highest concentration tested was the highest concentration that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation as confirmed by three pre-experiments. A control group of four mice was treated with the vehicle only. Five days after the first topical application, the mice were intravenously injected into a tail vein with radio-labelled thymidine (3H-methyl thymidine; 3HTdR). Approximately five hours after intravenous injection, the mice were sacrificed and the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was then determined by the incorporation of 3H-methyl thymidine measured in a β-scintillation counter.
- Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Mean values and standard deviations
- Positive control results:
- alpha- hexylcinnamaldehyde 25% (w/w) in acetone/olive oil (4+1, v/v): S.I. value of 9.5 and was therefore regarded as a sensitiser in the LLNA test, since the exposure to one or more test concentrations resulted in a 3-fold or greater increase in incorporation of 3HTdR compared with concurrent controls.
- Key result
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- 0.0% (w/w) in acetone/olive oil (4+1, v/v)
- Remarks on result:
- other: negative control
- Key result
- Parameter:
- SI
- Value:
- 0.84
- Test group / Remarks:
- 0.5% (w/w) in acetone/olive oil (4+1, v/v)
- Remarks on result:
- other: at 0.5% conc; not a skin sensitiser
- Key result
- Parameter:
- SI
- Value:
- 0.92
- Test group / Remarks:
- 1.0% (w/w) in acetone/olive oil (4+1, v/v)
- Remarks on result:
- other: at 1% conc; not a skin sensitiser
- Key result
- Parameter:
- SI
- Value:
- 1.22
- Test group / Remarks:
- 2.5% (w/w) in acetone/olive oil (4+1, v/v)
- Remarks on result:
- other: at 2.5% conc; not a skin sensitiser
- Cellular proliferation data / Observations:
- The animals did not show any signs of systemic toxicity during the course of the study and no cases of mortality were observed. The body weight of the animals, recorded prior to the first application and prior to treatment with 3HTdR, was within the range commonly recorded for animals of this strain and age. A very slight erythema (score: 1) was observed in the animals of the high dose group on test day 3. In this study, Stimulation Indices (S.I.) of 0.84, 0.92, and 1.22 were determined with the test substance at concentrations of 0.5, 1, and 2.5% (w/w) in acetone/olive oil (4+1, v/v), respectively. The test substance was not a skin sensitiser under the test conditions of this study.
(The estimated concentration of test substance required to produce a S.I. of 3 is referred to as the EC3 value. In this study, the EC3 value could not be calculated, since none of the tested concentrations induced a S.I. greater than the threshold value of 3.) - Interpretation of results:
- other: CLP criteria not met
- Remarks:
- does not need to be classified
- Conclusions:
- Under the study conditions, the test substance was not a skin sensitiser (LLNA).
- Executive summary:
A study was conducted to determine the skin sensitisation potential of the test substance according to OECD Guideline 429 and EU Method B.42, in compliance with GLP. Groups of 4 female CBA/Ca mice each were treated with 0, 0.5, 1, and 2.5% (w/w) preparations of the test substance in acetone/olive oil (4+1, v/v)) or with the vehicle alone. The highest concentration tested was the highest concentration that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation as confirmed by three pre-experiments. The study used 3 test groups and 1 control groups (vehicle). 25 µL of the respective test substance preparation or of the vehicle were applied to the dorsum of both ears of each animal once daily for three consecutive days. Five days after the first topical application, the mice were intravenously injected into a tail vein with radio-labelled thymidine (3H-methyl thymidine; 3HTdR). Approximately five hours after intravenous injection, the mice were sacrificed and the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was then determined by the incorporation of 3H-methyl thymidine measured in a β-scintillation counter. Mortality / viability was reported at least once daily from experimental start to necropsy. Body weights was measured prior to the first application and prior to treatment with 3HTdR. Clinical signs (local / systemic) were recorded at least once daily. The animals did not show any signs of systemic toxicity during the course of the study and no cases of mortality were observed. The body weight of the animals, recorded prior to the first application and prior to treatment with 3HTdR, was within the range commonly recorded for animals of this strain and age. A very slight erythema (score: 1) was observed in the animals of the high dose group on test day 3. In this study, Stimulation Indices (S.I.) of 1.00, 0.84, 0.92, and 1.22 were determined with the test substance at concentrations of 0, 0.5, 1, and 2.5% (w/w) in acetone/olive oil (4+1, v/v), respectively. The EC3 value could not be calculated, since none of the tested concentrations induced a S.I. greater than the threshold value of 3. Under the study conditions, the test substance was not a skin sensitiser (LLNA) (Roth, 2015).
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From May 14, 2001 to May 18, 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 404 (Acute Dermal Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2500 (Acute Dermal Irritation)
- Deviations:
- no
- GLP compliance:
- yes
- Specific details on test material used for the study:
- Batch no.: F016143 05
Appearance: Light-yellow, clear viscous liquid - Species:
- rabbit
- Strain:
- New Zealand White
- Remarks:
- females
- Details on test animals or test system and environmental conditions:
- Source: Charles River Wiga, D-97633
Acclimatization: 5 days
Body weight: 2.0-2.4 kg
Temperature: ca. 20.3°C, relative humidity : ca. 58.8% and light regimen: 12-hour light /12-hour dark cycle
Diet: laboratory food Altromin 2123, ad libitum
Water: tap water for human consumption, ad libitum - Type of coverage:
- semiocclusive
- Preparation of test site:
- clipped
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- 0.5 mL
- Duration of treatment / exposure:
- 4 h
- Observation period:
- 1, 24, 48 and 72 h after patch removal
- Number of animals:
- 3
- Details on study design:
- - Hair was clipped on the dorsal areas of the trunks one day before the application of the test substance. The test sites were median on the dorsal thoracal region. 0.5 mL of the test substance was applied via a cellulose patch to a site of about 2.5 cm x 2.5 cm of the intact skin of each of 3 rabbits and covered by a semi-occlusive dressing.
- The skins were examinated for local alterations one day before the administration of the test substance (after clipping of the hair) and immediately before the administration. The treated areas and the surrounding untreated skin (control area) of the animals were examinated (using a cold light source KL 1500 electronic) for erythema/eschar and oedema as well as for other local alterations approximately 1, 24, 48 and 72h after patch removal. The animals were analysed once daily.
- Primary irritation index was calculated according to EPA: all scores for erythema and oedema for the 3 animals and the 4 reading times were added and divided by 12. - Irritation parameter:
- erythema score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- >= 0 - <= 0
- Max. score:
- 0
- Reversibility:
- other: no effects were seen
- Remarks:
- no effects were seen
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- erythema score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- >= 0 - <= 0
- Max. score:
- 0
- Reversibility:
- other: no effects were seen
- Remarks:
- no effects were seen
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- erythema score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- >= 0 - <= 0
- Max. score:
- 0
- Reversibility:
- other: no effects were seen
- Remarks:
- no effects were seen
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- edema score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- >= 0 - <= 0
- Max. score:
- 0
- Reversibility:
- other: no effects were seen
- Remarks:
- no effects were seen
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- edema score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- >= 0 - <= 0
- Max. score:
- 0
- Reversibility:
- other: no effects were seen
- Remarks:
- no effects were seen
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- edema score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- >= 0 - <= 0
- Max. score:
- 0
- Reversibility:
- other: no effects were seen
- Remarks:
- no effects were seen
- Remarks on result:
- no indication of irritation
- Irritant / corrosive response data:
- All exposed skin sites were normal at each examination term; neither erythema/eschar nor oedema were observed. The primary irritation index was 0.0. The test substance was considered not irritating to the skin.
- Other effects:
- No general toxic effects of the test substance were observed.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- does not need to be classified
- Conclusions:
- Under the study conditions, the test substance was considered not irritating to rabbit skin.
- Executive summary:
An in vivo study was conducted to determine the skin irritation potential of the test substance according to OECD Guideline 404, EU Method B.4 and EPA-Guideline OPPTS 870.2500, in compliance with GLP. Hair of 3 female rabbits (New-Zealand White) was clipped on the dorsal areas of the trunks one day before the application of the test substance. 0.5 mL of the test substance was applied via a cellulose patch to a site of about 2.5 cm x 2.5 cm of the intact skin of each of 3 rabbits and covered by a semi-occlusive dressing. The skins were examined for local alterations one day before the administration of the test substance (after clipping of the hair) and immediately before the administration. The treated areas and the surrounding untreated skin (control area) of the animals were examined for erythema/eschar and oedema as well as for other local alterations approximately 1, 24, 48 and 72h after patch removal. The animals were analysed once daily. Primary irritation index was calculated according to EPA: all scores for erythema and oedema for the 3 animals and the 4 reading times were added and divided by 12. No general toxic effects of the test substance were observed. All exposed skin sites were normal at each examination term; neither erythema/eschar nor oedema was observed. The primary irritation index was 0.0. Under the study conditions, the test substance was considered not irritating to the skin (Wolf, 2001).
Data source
Materials and methods
Results and discussion
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.